EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization

Zahra Rooholamini, Hassan Dianat-Moghadam, Mahsa Esmaeilifallah, Hossein Khanahmad

Frontiers in Public Health · 05.07.2024 · 12

DOI: 10.3389/fpubh.2024.1382996 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Public Health, online erschienen am 05.07.2024. Verfasst von Zahra Rooholamini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Vaccines, Attenuated, Leishmaniasis, Cutaneous, Leishmaniasis Vaccines, Genetic Engineering. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the development of a vaccine against cutaneous leishmaniasis in preclinical and clinical studies, we still do not have a safe and effective vaccine for human use. Given this situation, the search for a new prophylactic alternative to control leishmaniasis should be a global priority. A first-generation vaccine strategy—leishmanization, in which live Leishmania major parasites are inoculated into the skin to protect against reinfection, is taking advantage of this situation. Live attenuated Leishmania vaccine candidates are promising alternatives due to their robust protective immune responses. Importantly, they do not cause disease and could provide long-term protection following challenges with a virulent strain. In addition to physical and chemical methods, genetic tools, including the Cre- loxP system, have enabled the selection of safer null mutant live attenuated Leishmania parasites obtained by gene disruption. This was followed by the discovery and introduction of CRISPR/Cas-based gene editing tools, which can be easily and precisely used to modify genes. Here, we briefly review the immunopathology of L. major parasites and then present the classical methods and their limitations for the production of live attenuated vaccines. We then discuss the potential of current genetic engineering tools to generate live attenuated vaccine strains by targeting key genes involved in L. major pathogenesis and then discuss their discovery and implications for immune responses to control leishmaniasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, AttenuatedLeishmaniasis, CutaneousLeishmaniasis VaccinesGenetic EngineeringLeishmania majorHumansAnimalsImmunizationGene Editing

Stichwörter der Autor:innen

CRISPRattenuated vaccinescutaneous leishmaniasisdrug resistanceimmunizationleishmanization

Substanzen

Vaccines, AttenuatedLeishmaniasis Vaccines

Autor:innen und Institutionen

  • Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Pediatric Inherited Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Zitieren

APA

Rooholamini, Z., Dianat-Moghadam, H., Esmaeilifallah, M., & Khanahmad, H. (2024). From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1382996

Vancouver

Rooholamini Z, Dianat-Moghadam H, Esmaeilifallah M, Khanahmad H. From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization. Frontiers in Public Health. 2024;12. doi:10.3389/fpubh.2024.1382996

BibTeX
@article{Rooholamini2024,
  author = {Rooholamini, Zahra and Dianat-Moghadam, Hassan and Esmaeilifallah, Mahsa and Khanahmad, Hossein},
  title = {From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization},
  journal = {Frontiers in Public Health},
  year = {2024},
  volume = {12},
  doi = {10.3389/fpubh.2024.1382996}
}
Kostenlos starten →